EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Defense DEF

Pharmacy issues related to the annual defense authorization and implementation of the 2018 NDAA.

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Office of Personnel Management (OPM); Food & Drug Administration (FDA); Congressional Budget Office (CBO); Federal Trade Commission (FTC); Medicare Payment Advisory Commission (MedPAC); White House Office; SENATE; Executive Office of the President (EOP); Internal Revenue Service (IRS); Government Accountability Office (GAO); Labor, Dept of (DOL); Health Resources & Services Administration (HRSA)

Taxation/Internal Revenue Code TAX

Implementation of tax provisions of the ACA and tax reform policies.

Contacted: Health Resources & Services Administration (HRSA); SENATE; Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); White House Office; Labor, Dept of (DOL); Food & Drug Administration (FDA); Federal Trade Commission (FTC); Office of Personnel Management (OPM); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Congressional Budget Office (CBO); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Health Issues HCR

Regulatory policies related to the health reform law, including drug benefits and disclosure. Implementation of HITECH. Prescription drug affordability issues, including biosimilars. Reforms to Medicaid and Exchange markets.

Contacted: Government Accountability Office (GAO); Internal Revenue Service (IRS); White House Office; Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); Health Resources & Services Administration (HRSA); Congressional Budget Office (CBO); SENATE; HOUSE OF REPRESENTATIVES; Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL)

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing the Part D coverage gap, direct negotiation of prescription drug prices. Researching and responding the Administration's America's Patients First drug pricing blueprint. Medicare Part B reforms. S. 637; HR 1920; HR 1939. Medical utilization management and Medicare Advantage program policy and operations; S. 2553 and S 2554 - Prohibition on pharmacy "gag clauses."

Contacted: Medicare Payment Advisory Commission (MedPAC); SENATE; Health Resources & Services Administration (HRSA); White House Office; Labor, Dept of (DOL); Food & Drug Administration (FDA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Internal Revenue Service (IRS); Congressional Budget Office (CBO); Office of Personnel Management (OPM); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES

Bills named: S. 2553 (115th), S. 637 (115th), H.R. 1939 (115th), H.R. 1920 (115th)

Pharmacy PHA

Design and coverage of pharmacy benefits in Exchanges and the commercial market, including: eRx, EPCS, electronic prior authorization, PBM disclosure, MLR, and specialty pharmacy tiering. Implementation of biosimilars pathway from BPCIA. Policies placing restrictions on pharmacy benefit design. Issues relating to prescription drug affordability. REMS reform. Prescription drug user fee reauthorization. HR 1854; S. 788; HR 2025; S. 2553 and S. 2554; HR 6.

Contacted: Health Resources & Services Administration (HRSA); Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Federal Trade Commission (FTC); White House Office; Government Accountability Office (GAO); SENATE; Labor, Dept of (DOL); Food & Drug Administration (FDA)

Bills named: S. 2553 (115th), S. 2554 (115th), H.R. 2025 (115th), H.R. 1854 (115th), H.R. 6 (115th), S. 788 (115th)